These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 34563471)

  • 1. COVID-19 associated with concomitant mucormycosis and aspergillosis.
    Lai CC; Wu CJ; Lee YC; Liu WL
    J Microbiol Immunol Infect; 2022 Apr; 55(2):353-354. PubMed ID: 34563471
    [No Abstract]   [Full Text] [Related]  

  • 2. COVID-19-associated mixed mold infection: A case report of aspergillosis and mucormycosis and a literature review.
    Benhadid-Brahmi Y; Hamane S; Soyer B; Mebazaa A; Alanio A; Chousterman B; Bretagne S; Dellière S
    J Mycol Med; 2022 Mar; 32(1):101231. PubMed ID: 34864498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual Fungal Infections (Aspergillosis and Mucormycosis) in a Diabetic Mellitus Patient Leading to Maxillary Sinusitis as a Post-COVID Manifestation: First Case Report.
    Jawanda MK; Narula R; Gupta S; Sharma V; Gupta P; Kaur M
    Acta Medica (Hradec Kralove); 2021; 64(4):227-231. PubMed ID: 35285446
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive mucormycosis and aspergillosis in a healthy 22-year-old battle casualty: case report.
    Radowsky JS; Strawn AA; Sherwood J; Braden A; Liston W
    Surg Infect (Larchmt); 2011 Oct; 12(5):397-400. PubMed ID: 22004440
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mucormycosis: A killer in the shadow of COVID-19.
    Suvvari TK; Arigapudi N; Kandi VR; Kutikuppala LS
    J Mycol Med; 2021 Sep; 31(3):101161. PubMed ID: 34146996
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined Orofacial Aspergillosis and Mucormycosis: Fatal Complication of a Recurrent Paediatric Glioma-Case Report and Review of Literature.
    Chermetz M; Gobbo M; Rupel K; Ottaviani G; Tirelli G; Bussani R; Luzzati R; Di Lenarda R; Biasotto M
    Mycopathologia; 2016 Oct; 181(9-10):723-33. PubMed ID: 27350324
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mixed mold infection with
    Bellanger AP; Navellou JC; Lepiller Q; Brion A; Brunel AS; Millon L; Berceanu A
    Infect Dis Now; 2021 Oct; 51(7):633-635. PubMed ID: 33527098
    [No Abstract]   [Full Text] [Related]  

  • 8. Coronavirus disease 2019 associated pulmonary mucormycosis.
    Panigrahi MK; Singh P; Mishra P; Durgeshwar G
    Infection; 2023 Oct; 51(5):1601-1602. PubMed ID: 37067756
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-COVID-19 Intestinal and Mesenteric Mucormycosis.
    Banerjee N; Lodha M; Kompally P; Chawla S
    Am Surg; 2023 Jun; 89(6):2770-2773. PubMed ID: 34730420
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Gastric Ulcers in An Immunosuppressed Patient with COVID-19 Infection caused by Mucormycosis.
    He D; Wang Z
    J Gastrointestin Liver Dis; 2024 Mar; 33(1):16. PubMed ID: 38554417
    [No Abstract]   [Full Text] [Related]  

  • 11. Aplastic anemia, mucormycosis and aspergillosis in infectious mononucleosis: success is possible.
    Ergene U; Ozbalci D; Baykal B; Metin Ciris I; Yariktas M
    Transfus Apher Sci; 2007 Oct; 37(2):125-9. PubMed ID: 17959418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disseminated acute concomitant aspergillosis and mucormycosis in a pony.
    Thirion-Delalande C; Guillot J; Jensen HE; Crespeau FL; Bernex F
    J Vet Med A Physiol Pathol Clin Med; 2005 Apr; 52(3):121-4. PubMed ID: 15836442
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Disseminated aspergillosis and mucormycosis. A case report].
    Mölle M; Blaschke-Hellmessen R; Schuler U; Nowak R; Ehninger G
    Mycoses; 1996; 39 Suppl 1():59-64. PubMed ID: 8767273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Case Report: Immune Checkpoint Blockade Plus Interferon-Γ Add-On Antifungal Therapy in the Treatment of Refractory Covid-Associated Pulmonary Aspergillosis and Cerebral Mucormycosis.
    Serris A; Ouedrani A; Uhel F; Gazzano M; Bedarida V; Rouzaud C; Bougnoux ME; Raphalen JH; Poirée S; Lambotte O; Martin-Blondel G; Lanternier F
    Front Immunol; 2022; 13():900522. PubMed ID: 35720319
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Mucormycosis of the face associated with aspergillosis in the diabetic patient. Diagnostic and therapeutic considerations].
    Bonfils P; Trotoux J
    Ann Otolaryngol Chir Cervicofac; 1989; 106(6):327-9. PubMed ID: 2817670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant mucormycosis complicating coronavirus disease 2019 (COVID-19).
    Karimi-Galougahi M; Arastou S; Haseli S
    Int Forum Allergy Rhinol; 2021 Jun; 11(6):1029-1030. PubMed ID: 33713565
    [No Abstract]   [Full Text] [Related]  

  • 17. Simultaneous disseminated aspergillosis and zygomycosis in a leukemic patient.
    Scheld WM; Royston D; Harding SA; Hess CE; Sande MA
    South Med J; 1979 Oct; 72(10):1325-8. PubMed ID: 290047
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Nervous system lesions in mycoses].
    Kanareĭkin KF; Bakhur VT; Eskin MA
    Klin Med (Mosk); 1984 Feb; 62(2):10-9. PubMed ID: 6368964
    [No Abstract]   [Full Text] [Related]  

  • 19. Coinfection pulmonary mucormycosis and aspergillosis with disseminated mucormycosis involving gastrointestinalin in an acute B-lymphoblastic leukemia patient.
    Hu ZM; Wang LL; Zou L; Chen ZJ; Yi Y; Meng QB; Feng Y
    Braz J Microbiol; 2021 Dec; 52(4):2063-2068. PubMed ID: 34218427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aspergillosis and Mucormycosis in COVID-19 Patients: A Systematic Review.
    Afzal S; Nasir M
    J Coll Physicians Surg Pak; 2022 May; 32(5):639-645. PubMed ID: 35546702
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.